ReviewDermatology practical & conceptual2025
Evaluation of Clinical Studies of Patients With Dermatophyte Infections Caused by Trichophyton indotineae: Treatment Response and Resistance to Antifungal Medications.
Review in Dermatology practical & conceptual, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDermatophytoses are the most frequent fungal infections of the skin. It has been reported that dermatophyte infections resistant to antifungal medications have increased in recent years. Therefore, superficial fungal skin infections that are difficult to treat have become a major health problem worldwide. Trichophyton indotineae is a newly described dermatophyte species that has been mainly isolated from patients with dermatophytosis characterized by widespread skin lesions and resistance to antifungal treatment and that causes outbreaks. T. indotineae leads to a pruritic rash that affects the large areas of the body surface such as the trunk, groin, and extremities, even in immunocompetent patients. Moreover, these patients usually do not respond to systemic terbinafine, which is the first-line treatment for dermatophyte infections and has fungicidal effects.
objectivesOur aim was to determine the body sites affected by T. indotineae infection, the types of tinea caused by T. indotineae, the drugs to which it is particularly resistant, and the treatment regimens to which it responds.
methodsArticles in the PubMed database published between December 2020 and September 2024 were investigated by searching the word "Trichophyton indotineae".
resultsWe reviewed 39 studies in the PubMed database that reported patients with T. indotineae infection to identify treatment regimens to which it is resistant or responsive.
conclusionTreatment guidelines should be established to select the appropriate alternative antifungal medication and determine the adequate drug dose and duration in treatment-resistant fungal skin infections caused by T. indotineae. Nevertheless, the data required to develop standard treatment regimens are insufficient.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.